Covid-19

Prova in India del sistema di somministrazione del vaccino Covid-19

di
Condividi:

L'India testa il suo sistema di somministrazione del vaccino Covid-19 con una prova a livello nazionale sabato 2 gennaio, mentre si prepara a lanciare un programma di inoculazione per arginare la pandemia di coronavirus. L'esercizio include l'inserimento dei dati necessari in una piattaforma online per il monitoraggio della distribuzione del vaccino, insieme al test della conservazione a freddo e delle modalità di trasporto del vaccino. Durante la prova 25 operatori sanitari hanno ricevuto vaccini fittizi in ciascuno dei centri da utilizzare in tutto il Paese in un test prima del lancio.

Personale sanitario indiano testa il sistema di somministrazione del vaccino Covid-19. Sabato 2 gennaio 2021, India. Foto: AP /Altaf Qadri e Mahesh Kumar A.
A health worker, left, speak with people participating in a COVID-19 vaccine delivery system trial in New Delhi, India, Saturday, Jan. 2, 2021. India tested its COVID-19 vaccine delivery system with a nationwide trial on Saturday as it prepares to roll-out an inoculation program to stem the coronavirus pandemic. Saturday’s exercise included necessary data entry into an online platform for monitoring vaccine delivery, along with testing of cold storage and transportation arrangements for the vaccine, the health ministry had said.(AP Photo/Altaf Qadri)
A health worker, left, checks the body temperature of a woman as a precaution against the coronavirus before allowing her to participate in a COVID-19 vaccine delivery system trial in New Delhi, India, Saturday, Jan. 2, 2021. India tested its COVID-19 vaccine delivery system with a nationwide trial on Saturday as it prepares to roll-out an inoculation program to stem the coronavirus pandemic. Saturday’s exercise included necessary data entry into an online platform for monitoring vaccine delivery, along with testing of cold storage and transportation arrangements for the vaccine, the health ministry had said.(AP Photo/Altaf Qadri)
People participating in a COVID-19 vaccine delivery system trial wait for their turn at a COVID-19 vaccination center in New Delhi, India, Saturday, Jan. 2, 2021. India tested its COVID-19 vaccine delivery system with a nationwide trial on Saturday as it prepares to roll-out an inoculation program to stem the coronavirus pandemic. Saturday's exercise included necessary data entry into an online platform for monitoring vaccine delivery, along with testing of cold storage and transportation arrangements for the vaccine, the health ministry had said. (AP Photo/Altaf Qadri)
A health worker participates in a COVID-19 vaccine delivery system trial in Hyderabad, India, Saturday, Jan. 2, 2021. India tested its COVID-19 vaccine delivery system with a nationwide trial on Saturday as it prepares to roll-out an inoculation program to stem the coronavirus pandemic. Saturday's exercise included necessary data entry into an online platform for monitoring vaccine delivery, along with testing of cold storage and transportation arrangements for the vaccine, the health ministry had said.(AP Photo/Mahesh Kumar A.)
Health workers participate in a COVID-19 vaccine delivery system trial in Hyderabad, India, Saturday, Jan. 2, 2021. India tested its COVID-19 vaccine delivery system with a nationwide trial on Saturday as it prepares to roll-out an inoculation program to stem the coronavirus pandemic. Saturday's exercise included necessary data entry into an online platform for monitoring vaccine delivery, along with testing of cold storage and transportation arrangements for the vaccine, the health ministry had said.(AP Photo/Mahesh Kumar A.)
A health worker engages in a COVID-19 vaccine delivery system trial in New Delhi, India, Saturday, Jan. 2, 2021. India tested its COVID-19 vaccine delivery system with a nationwide trial on Saturday as it prepares to roll-out an inoculation program to stem the coronavirus pandemic. Saturday’s exercise included necessary data entry into an online platform for monitoring vaccine delivery, along with testing of cold storage and transportation arrangements for the vaccine, the health ministry had said.(AP Photo/Altaf Qadri)

L’India, un Paese con 1,3 miliardi di abitanti, è il secondo al mondo in numero di contagi, con oltre 10,305 milioni di persone infette da Covid-19. Venerdì 1 gennaio è stato approvato l’uso di emergenza del primo vaccino anti Covid-19. Si tratta del vaccino sviluppato da AstraZeneca e dall’Università di Oxford, prodotto dal Serum Institute dell’India, il più grande produttore di vaccini al mondo. Il governo indiano prevede la vaccinazione di 300 milioni di persone durante la prima metà del 2021. I primi gruppi a ricevere le prime dosi saranno 30 milioni di operatori sanitari, poliziotti, soldati e volontari, e 270 milioni di persone in situazione di vulnerabilità.

Guarda anche

Siti amici

Edicola Digitale Città Nuova - Reader Scarica l'app
CittaNuova.it
Simple Share Buttons